Concepedia

Silun Xu

SX

Statistics

Publications

3

Citations

70

H-Index

3

Active since

2018

Affiliations

Harbin Medical University(Current)

Macau University of Science and Technology

Second Affiliated Hospital of Harbin Medical University

Silun Xu is an author at Harbin Medical University specializing in pharmacology, medicine, and anthracycline cardiotoxicity.

Publications per year

2018–2021

3

Publications

3

LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy

Ying Yu, Yumiao Pan, Ziyi Fan et al. · Frontiers in Cell and Developmental Biology · 2021 · 34 citations · Full text

, , +17

Metabolites Identification of Bioactive Compounds Daturataturin A, Daturametelin I, N-Trans-Feruloyltyramine, and Cannabisin F From the Seeds of Datura metel in Rats

Silun Xu, Yan Liu, Xiang Ling et al. · Frontiers in Pharmacology · 2018 · 23 citations · Full text

, , +12

MicroRNA-98 ameliorates doxorubicin-induced cardiotoxicity via regulating caspase-8 dependent Fas/RIP3 pathway

Yang Pan, Yumiao Pan, Fang-tong Liu et al. · Environmental Toxicology and Pharmacology · 2021 · 13 citations

, , +14

1–3 of 3